No AIDS Vaccines on the Near Horizon
WebMD News Archive
Within the drug classes already available, Eron described new agents that are in later stages of testing that could offer once or twice daily dosing and improved action against resistant HIV strains.
Looking forward, Eron says, "We're going to have true once daily ... regimens. ... We will [also] have better treatment options for the highly treatment-experienced patient, and it will be simpler for those people too." He also expects that there eventually will be more therapeutic options for patients to try, although he warns that novel drugs are years away from regular clinical use.